Vaxonyx

Vaxonyx is an AI-powered biotechnology company based in Huntsville, Alabama, specializing in the development of innovative genetic, vaccine, and immunotherapy solutions. Leveraging the power of artificial intelligence and molecular biology, we accelerate the discovery and design of next-generation therapeutics, making biomedical innovation accessible and affordable for researchers and healthcare systems worldwide. Our core expertise lies in neoantigen discovery, vaccine design, and translational immunology, underpinned by our integrated DNA Delivery Platform and robust preclinical R&D capabilities. We are committed to transforming scientific breakthroughs into real-world health solutions, driven by a multidisciplinary team of scientists and engineers led by Dr. Kempaiah Rayavara, a seasoned biotech executive with a proven track record in preclinical research and development. Vaxonyx’s vision is to lead globally in AI-driven biotechnology by creating advanced DNA platforms that revolutionize vaccine and gene therapy development, setting new standards for precision and effectiveness.